Congress of the International Society on Thrombosis and Haemostasis

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

D
Da Costa Martins P.	-	a₄ integrins and P-selectin mediate rolling and initial attachment of platelet-monocyte complexes to activated endothelium under flow conditions
Da Cunha V.	-	Activated thrombin–activatable fibrinolysis inhibitor (TAFIa) prevents spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs
Daama S.	-	Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies
Dabrowska M.	-	Calpain inhibitor calpeptin enhances the activity of the 20S proteasome in intact and calcium ionophore-stimulated platelets
DACUS, INVESTIGATORS	-	Optimal duration of oral anti-coagulant therapy after the first episode of deep vein thrombosis of the lower limbs: a randomized study based on the recanalization of the veins detected by ultrasonography
Daenens K.	-	Platelet recruitment in vivo to injured blood vessels is not prevented by GPIIb/IIIa antagonism
Dafforn T. R.	-	Human glycoprotein VI: identification and blockade of the collagen-binding surface
Dahl O.	-	Development of anticoagulant drugs - using orthopedic surgery as a proof of principle
Dahl O. E.	-	Pharmacokinetics of BIBR 953 ZW, the active form of the oral direct thrombin inhibitor BIBR 1048, in patients undergoing hip replacement
Dahl O.	-	Improving VTE prophylaxis standards of care
Dahl O. E.	-	Individualizing the risk of venous thromboembolism in medical and surgical patients: development of the decision matrix for VTE prophylaxis
	-	Efficacy and safety of the treatment regimen of melagatran and ximelagatran for prevention of thromboembolic events after total hip or knee replacement: a meta-analysis of 3 randomized, double-blind studies, to evaluate the influence of time and dose
Dahlba B.	-	Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized
Dahlback B.	-	Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding
Dahlbäck B.	-	Gla-domain mutated human protein C demonstrating enhanced inactivation of both factor Va and factor VIIIa
Dahlbäck B.	-	Effects of Factor Xa and protein S on the individual APC-cleavage sites of factor Va
Dahlbäck B.	-	Functional properties of recombinant factor Va mutated in a potential calcium-binding site
Dahlback B.	-	Coagulation factor V Leiden not increased in pregnancies complicated by abruptio placentae
Dahlbäck B.	-	Inhibition by prothrombin of individual activated protein C-mediated cleavages in factor Va
Dahlback B.	-	H1299R mutation results in retention of mutant factor V molecule in the Golgi complex: a possible novel type of quantitative defect
	-	Identification of the multimerin binding region within the C2 domain of human factor V using constructs generated by alanine scanning and site-directed mutagenesis
Dahlbäck B.	-	Changed inactivation pathway of factor Va by activated protein C in the presence of heparin
Dahlback B.	-	Inefficient secretion and intracellular degradation of factor V
Dahlbäck B.	-	Molecular recognition in the protein C anticoagulant pathway
Dahlback B.	-	Functional characterization of recombinant Factor V Liverpool: Ile350Thr, a novel mutation associated with thrombosis
Dahlbäck B.	-	Effects of protein S and phospholipid on individual APC-cleavage sites in factor Va
Dahlback B.	-	Functional characterization of recombinant factor V molecules mimicking the R2-haplotype
	-	Severe thrombophilia in two brothers due to novel combination of mutations in factor V gene producing quantitative deficiency (Glu119Term) and decreased sensitivity to activated protein C due to a novel glycosylation site (Ile359Thr-FV Liverpool)
Dailiana Z.	-	Is the G455A polymorphism of the fibrinogen beta gene associated with osteonecrosis? A preliminary report
	-	Mutations of the methylenetetrahydrofolate reductase (MTHFR) gene and osteonecrosis. A preliminary report
Dake M.	-	A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Dal Bello F.	-	Pseudogene coamplification mimicking a 14-bp deletion mutation in exon 5 of plasminogen gene: a methodological study
Daleskog M.	-	Acute hyperglycemia enhances platelet secretion but not platelet aggregation
	-	Clopidogrel treatment reduces platelet activity in vivo, but does not counteract exercise-induced platelet activation
	-	Enhanced platelet and leukocyte activation by strenuous exercise in type I diabetes mellitus
	-	Clopidogrel treatment provides limited protection against exercise-induced platelet-leukocyte conjugation
	-	Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins
	-	Platelet function and inflammatory markers in patients with type 1 diabetes with and without microvascular complications
	-	Enhanced leukocyte-platelet cross-talk in type 1 diabetes mellitus
D'Alessandro R.	-	Soluble CD40 ligand (sCD40L) plasma levels in nonsmall cell lung cancer
Dali F.	-	In vitro and ex vivo study of the effects of core pentasaccharide and of longer heparin chains on latent antithrombin (AT)
	-	LPS-activation of THP-1 cells: effect of anti-thrombin studied by in vivo footprinting of the tissue factor (TF) gene promoter
Dallongeville J.	-	Tissue factor predicts long-term outcome after percutaneous coronary revascularization
D'Alteroche L.	-	G20210A prothrombin gene mutation appears as the most important inherited prothrombotic risk factor in ‘idiopathic’ portal vein thrombosis
Daly M. E.	-	Analysis of storage and regulated secretion of three human variants of von Willebrand factor provides new insights into von Willebrand's disease
	-	Comparison of cytotrophoblast gene expressed in normal and pre-eclamptic placenta
	-	A novel type 1 von Willebrand disease causing mutation (S49R) in the von Willebrand factor pro-peptide that affects von Willebrand factor multimerization and secretion
	-	The prevalence of, and molecular defects underlying, inherited Protein S deficiency in the general population
Daly M.	-	Basal Fibrinogen and FVIII:C Concentrations are not Associated with Polymorphisms in the Interleukin-1 Gene Cluster
Daly M. E.	-	Can full-length wild-type von Willebrand factor (VWF) or the VWF propeptide rescue secretion of the R273W VWF variant associated with quantitative deficiency?
Damås J. K.	-	Interleukin-7-mediated inflammation in unstable angina – possible role of chemokines and platelets
D'Amico E.	-	Successful use of Arixtra® in a patient with PNH, Budd–Chiari syndrome and HIT
	-	Acquired prothrombotic-associated factors in cerebral venous thrombosis (CVT)
	-	Inherited prothrombotic risk factors in a Brazilian cohort with CVT
D'Amico E. A.	-	Venous thromboembolism (VTE) in children: a series of cases from a pediatric Brazilian cohort
	-	Factor VII deficiency and stroke: case report
Dampier K.	-	The effects of folic acid supplements on coagulation status in pregnancy
D'Andrea G.	-	FV plasma levels and the activated protein C resistance phenotype are modulated by the FV gene Asp79His polymorphism in presence of the FV Leiden mutation
D'Andrea G.	-	Modulation of clinical phenotype of Glanzmann's Thrombasthenia by the C807T alpha2 gene polymorphism
Daneman A.	-	Central venous catheter (CVC) related thrombosis in boys with hemophilia
Danesh J.	-	The epidemiology of coagulation variables in coronary artery disease
D'Angelo F.	-	Prevalence of haemostatic abnormalities in women with 3 or more implantation failures after in vitro fertilization
D'Angelo U.	-	Coagulation and complement inhibitors levels predict outcome in patients with severe sepsis
Daniel L.	-	Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration
Danloy S.	-	Overexpression of the platelet P2X₁ ion channel in transgenic mice generates a novel prothrombotic phenotype
Daraktchiev A.	-	Influence of time interval after sampling on variability of thrombelastography (TEG) results
Dardik R.	-	Prevalence of circulating procoagulant microparticles in allogeneic stem cell transplantation (alloSCT) for hemato-oncological malignancies
	-	Clot from platelet rich plasma promotes wound healing
Dardik R.	-	FXIII promotes endothelial cell migration, proliferation, and inhibits apoptosis
Dargaud Y.	-	Three abnormal patterns for inversion breaking intron 1 of the FVIII gene
Dargaud Y.	-	Human factor IX expression in megakaryocytes derived from electrophorated human hematopoietic cells
Dargaud Y.	-	Thrombin generation in von Willebrand diseases
Dargaud Y.	-	In vitro flow cytometry and functional testing of fresh and cryopreserved platelets
Das R.	-	Prevalence of factor V Leiden and FV HR2 haplotypes as risk factors for deep vein thrombosis: a study from north India
Das Gupta A.	-	Elevated factor VIII: a possible link between periodontal disease and acute coronary syndrome
Das Gupta A.	-	Local and clinical factors are the likely cause of venous thrombosis in lower limb arthroplasty
Dasani H.	-	Factor X Cardiff and Factor X Newcastle: Two new FX mutations associated with low activity and antigen levels
Dasi M. A.	-	Insufficient thromboxane A2 inhibition in patients with vascular disease chronically treated with aspirin: implications for platelet function
Daskalaki K.	-	Left adrenal hemorrhage with intravascular coagulation- case report
Dastur F. D.	-	Local and clinical factors are the likely cause of venous thrombosis in lower limb arthroplasty
Dastych J.	-	Up-regulation of plasminogen activator inhibitor-1 (PAI-1) by thymosinb 4 in endothelial cells
DATA MONITORING BOARD GERMAN REFACTO PE‡	-	Assessment of the inhibitor development in previously untreated patients (PUPs) suffering from hemophilia A treated with rFVIII: continuous evaluation of the German Pharmacovigilance Evaluation (PE) with ReFacto & reg
D'Atri L. P.	-	Prostacyclin protects basal and nitric oxide-induced megakaryocytes apoptosis
Datta Y. H.	-	Genetic and physical mapping of the platelet disorder in the fawn-hooded hypertensive rat
Datta M. W.	-	Genetic and physical mapping of the platelet disorder in the fawn-hooded hypertensive rat
Dauer R.	-	Mechanism of activation in Eastern tiger snake bite
Daugela L.	-	Genetic profiling of 20 patients with FVII deficiency by dHPLC and sequence analysis: detection of 7 novel mutations
Daurès J. P.	-	Antiphospholipid/antiprotein antibodies and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case–control study
Dautzenberg M-D.	-	Anti-thrombin F229L: a new homozygous variant leading to spontaneous anti-thrombin polymerization in vivo and severe childhood thrombosis
Dauzat M.	-	Antiphospholipid/antiprotein antibodies and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case–control study
	-	Anti-protein Z antibodies in women with abnormal pregnancies
Davenport P	-	The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia
Davì G.	-	Soluble CD40 ligand (sCD40L) plasma levels in nonsmall cell lung cancer
David D.	-	Molecular basis of inherited anti-thrombin deficiency in Portuguese families: identification of underlying molecular defects and screening for additional thrombotic risk factors
David M.	-	Specific and nonspecific antiphospholipid antibodies in recurrent fetal loss: a meta-analysis
David-Dufilho M.	-	Thrombomodulin regulates activity, localization and expression of nitric oxide synthase inhuman umbilical vein endothelial cells (HUVECs)
	-	Intravenous immunoglobulins G modulate calcium signals, von Willebrand factor secretion and nitric oxide metabolism in human endothelial cells
Davidson S. J.	-	Endothelial cell damage as shown by raised soluble-thrombomodulin and total von Willebrand factor antigen levels during heparin induced thrombocytopenia
Davidson S. R.	-	The development of an automated, real time, oral anticoagulant dosing module to enhance traditional computerized decision support software (CDSS)
Davidson B.	-	Patients with adverse pregnancy outcome have lower levels of protein Z and protein S compared to patients with normal pregnancy outcome
Davidson S. J.	-	A patient with factor V Leiden who rapidly developed fatal heparin induced thrombocytopenia
Davidson S. J.	-	A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique
Davidson S. J.	-	Thrombin potential in heparin induced thrombocytopenia
Davidson B.	-	Normal pregnancy is associated with decreased protein Z levels in the second and third trimesters compared to early pregnancy
Davidson B. L.	-	Symptomatic chronic thromboembolic pulmonary hypertension after symptomatic pulmonary embolism: incidence and risk factors: a long-term follow-up study
Davidson S.	-	Teicoplanin-dependent platelet antibodies as a cause of severe thrombocytopenia
Davidson B. L.	-	Fondaparinux vs. placebo for the prevention of venous thromboembolism in acutely ill medical patients (artemis)
Davies P.	-	Flow-induced alterations in endothelial cells: regional genomics of atherosclerosis susceptibility
Davies I.	-	Characterization of anti-factor VIII antibodies using Time-Resolved Fluoroimmunoassay
Davies M. H.	-	Inhibition of retinal neovascularization in mice by antisense phosphorodiamidate morpholino oligomer against a_v integrins
Davies R. J. O.	-	Increased circulating cardiovascular risk factors in obstructive sleep apnoea and the effect of CPAP therapy
Davies J.	-	The influence of the substitution of arginine within the RGD tripeptide motif of dendroaspin on its activity as a potent inhibitor of platelet aggregation and cell adhesion
	-	Peri-operative bleeding in patients with Pseudomyxoma peritonei appears to relate to trauma induced hypofibrinogenemia
Davies C.	-	Management of pulmonary embolism: Can we consider outpatient treatment?
Davies J.	-	Development of bifunctional inhibitors of both platelet aggregation and factor Xa
Davies R.	-	Population-based study of acquired hemophilia A
Davis R.	-	Issues in monitoring direct thrombin inhibitors: comparison of a new, rapid Ecarin Clotting Time (ECT) test to activated clotting time (ACT) and anti-IIa assays
Davoli P. G.	-	Contemporary total hip and knee replacement in A patients with haemophilia and high titre of inhibitors to FVIII by using recombinant FVIIa (novoseven) continuous infusion
	-	Intron 1 factor VIII gene inversion in patients with severe hemophilia A
Davood M.	-	Thrombocytopenia in HIV-infected patients, a report from HIV/AIDS Counseling and Care Center in Kermanshah, Iran
Dawson D.	-	Comparison of the clinical utility of two D-dimer tests (IL Test and Simpify) in the diagnosis of pulmonary embolism
Day T.	-	Protein Z-dependent protease inhibitor (ZPI) deficiency: a new thrombotic risk factor?
de Agostini A.	-	Anticoagulant heparan sulfate proteoglycans in mammalian reproductive function
De Alarcon P.	-	Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto^®) for surgical procedures in pediatric patients with severe hemophilia A
de Andrade M.	-	Genetic susceptibility of venous thromboembolism: role of the procoagulant, anticoagulant, fibrinolytic, and acute inflammation pathways
De Andrade M.	-	Familial segregation of venous thromboembolism
De Anglis A.	-	The Rapidpoint™ ENOX point-of-care test has strong correlation with anti-Xa levels for detecting the anti-coagulant effects of enoxaparin
De Biase L.	-	Enhanced TNF-a and oxidative stress in patients with heart failure: effect of TNF-a on platelet O₂ production
De Biasi E.	-	Intron 1 factor VIII gene inversion in patients with severe hemophilia A
	-	Contemporary total hip and knee replacement in A patients with haemophilia and high titre of inhibitors to FVIII by using recombinant FVIIa (novoseven) continuous infusion
De Bosch N.	-	Comparison of hemorrhagic symptoms in obligatory carriers of type 1 and type 3 von willebrand disease (VWD): results from a collaborative, international, multicenter study
	-	Clinical presentation of type 1 von Willebrand disease (VWD) in obligatory carriers: final results from a collaborative, international, multicenter study
De Carolis S.	-	Inherited thrombophilia and associated risk for unexplained fetal loss
De Caterina R.	-	NAD(P)H oxidase C242T gene variations and cardiovascular protection
De Caterina R.	-	Clopidogrel plus aspirin in the prevention of thromboembolism in cardioverted atrial fibrillation: results of the clopidogrel aspirin atrial fibrillation (CLAAF): a pilot study
	-	Inhibition of 3-Hydroxy-3-methylglutaryl coenzyme-A reductase attenuates expression of inducible nitric oxide synthase in cardiac myoblasts – Possible link to direct myocardial protection during ischemia-reperfusion
	-	Insulin enhances vascular cell adhesion molecule (VCAM-1) expression in human cultured endothelial cells – a link to the pathogenesis of accelerated atherosclerosis in diabetes
De Caterina R.	-	Statins inhibit cyclo-oxygenase (cox)-2 and metalloproteinase (mmp)-9 expression in human endothelial cells: possible contribution to plaque stability
	-	At least two distinct pathways generating reactive oxygen species mediate endothelial VCAM-1 induction by advanced glycation endproducts
De Chiara B.	-	Blood glutathione detects pro-oxidant patterns in mild hyperhomocysteinemia associated with atherothrombotic vascular events
De Cristofaro R.	-	The interaction of the 268–282 region of GpIba with the heparin binding site of thrombin inhibits the enzyme activation of Factor VIII
De Cristofaro R.	-	A naturally homozygous deletion mutation of LYS9 or LYS10 in the A-chain of alpha-thrombin reduces the catalytic efficiency of the enzyme
De Curtis A.	-	Effect of extra virgin olive oil on experimental thrombosis and primary haemostasis in rats
De Curtis A.	-	Pharmacological and cellular bases of some anti-thrombotic properties of extravirgin olive oil: studies on oleuropein and hydroxytyrosol
De Faire U.	-	The t-PA/PAI-1 complex in plasma in relation to risk of myocardial infarction as evaluated in the Stockholm heart epidemiological program (SHEEP)
De Filippis V.	-	The interaction of the 268–282 region of GpIba with the heparin binding site of thrombin inhibits the enzyme activation of Factor VIII
De Gaetano G.	-	Polymorphisms of the interleukin 1-b gene, inflammatory and hemostatic response and the risk of premature myocardial infarction
	-	Injection of the inflammatory peptide fMLP in the rabbit induces transient myocardial ischemia: role of thromboxane A2
	-	Are daily doses of 80 and 160 mg of aspirin bioequivalent? A pharmacokinetic and pharmacodynamic approach
	-	Effect of extra virgin olive oil on experimental thrombosis and primary haemostasis in rats
	-	Resveratol and quercetin inhibit tissue factor expression in vascular cells by preventing IkappaBalpha degradation and c-Rel/p65 activation
De Gironcoli M.	-	Efficacy of Haemate P in the management of patients with von Willebrand disease undergoing surgery
De Goede-Bolder A.	-	Mortality of Dutch hemophilia patients, a prospective follow-up of 973 patients, 1992–2002
	-	An evaluation of 30 years of hemophilia treatment in the Netherlands
	-	The development and evaluation of a quality of life questionnaire for children with hemophilia
De Groot P. G.	-	Importance of beta-2 glycoprotein I in the lupus anticoagulant cofactor effect: a case report
	-	Enhanced procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in plasma from patients with severe haemophilia A
	-	An in vivo model to study von Willebrand factor (VWF) clearance: fundamental aspects and application to the Arg1205His Vicenza mutation
	-	Recombinant factor VIIa restores adhesion and aggregation of a IIbb 3-deficient platelets in vitro
	-	Dimers of b2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2: an explanation for arterial thrombosis in the anti-phospholipid syndrome
	-	The low frequency allele of glycoprotein VI raises the threshold for platelet activation by collagen and collagen-related peptides
	-	The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasma
	-	IgG isolated from plasmas of patients with the anti-phospholipid syndrome binds to domain I of beta2-glycoprotein I
	-	Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting factor Xa, but not by those inhibiting thrombin or tissue factor
	-	Human glycoprotein VI: identification and blockade of the collagen-binding surface
	-	Thrombopoietin increases platelet adhesion and decreases rolling to von Willebrand factor
De Groot F.	-	The sensitivity and specificity of ADAMTS13 activity for primary thrombotic thrombocytopenic purpura
De Groot K.	-	Cost-effectiveness of fondaparinux (Arixtra^®) compared with enoxaparin as prophylaxis against venous thromboembolism following major orthopedic surgery
De Groot P. H. G.	-	Elevated levels of d-dimer and fragment 1 + 2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis
De Groot P. G.	-	Binding of b2-glycoprotein I and dimeric b2-glycoprotein I to members of the low-density lipoprotein receptor superfamily: implications for the anti-phospholipid syndrome
	-	Dimerization of beta2-glycoprotein I is necessary for binding to and activation of endothelial cells
De Groot F.	-	Evaluation of an automated von Willebrand factor (vWF) antigen assay
De Jong M.	-	Identification of transcription factor binding sites for HNF1-alpha, FOXA2, HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer
	-	The -148C/T variation in the human fibrinogen b promoter influences basal and IL-6 induced transcription and affects binding of nuclear proteins
De Jonge I.	-	Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
De Jonge E.	-	Prospective assessment of the diagnostic accuracy of the ISTH criteria for the diagnosis of DIC
De La Cadena R. A.	-	Regulation of connective tissue growth factor (CTGF) in synovial lining and modulation of the disease course of acute arthritis in an experimental model of rheumatoid arthritis by residues D793-P824 derived from thrombospondin-1-type 3 repeats
De La Peña A.	-	Lipoprotein (a) polymorphisms in Mexican-Amerindian populations
De Laat H. B.	-	Dimerization of beta2-glycoprotein I is necessary for binding to and activation of endothelial cells
	-	IgG isolated from plasmas of patients with the anti-phospholipid syndrome binds to domain I of beta2-glycoprotein I
De Lange M.	-	Genetics of fibrin clot structure and interactions with factor XIII: a twin study
De Larrañaga G.	-	Differences in Th1- and Th2-like cytokine patterns between patients with antiphospholipid syndrome and with lepromatous leprosy-related aPL
	-	Autoantibodies to TFPI are associated with definite APS but not with infection-related aPL
De Larrañaga G.	-	Insulin resistance status and truncal fat are important determinants of plasminogen activator inhibitor type-1 (PAI-1) levels in HIV infected patients
	-	Increased levels of endothelial injury marker in close relationship with lipoatrophy in HIV infected patients under high active antiretroviral treatment
de Leon C. M. M. P.	-	Prothrombin mutation G20210A, and not factor V Leiden, is a significant risk factor for cerebral venous thrombosis in 27 Brazilian patients
De Lisa E.	-	Association between recurrent pregnancy loss and prothrombotic gene polymorphisms
De Lorenzo F.	-	Identification of individuals at high risk of developing Ischaemic Heart Diseases
	-	Risk of recurrent thrombotic events in patients with coronary heart disease and left ventricular dysfunction
De Lucas J. C.	-	Retrospective analysis of heritable thrombophilia in 90 children with Legg-Perthes disease
De Lucia D.	-	Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
De Lucia S.	-	Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism
De Lucia D.	-	Transdermal hormone replacement therapy does not affect hemostasis and inflammation
	-	Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
De Maat M. P. M.	-	Decrease of thrombophilia variables by aggressive vs. conventional atorvastatin treatment in patients with type 2 diabetes mellitus
De Maat M. P.	-	Effects of dietary fish oil on coagulation and platelets
De Maat M. P. M.	-	The -148C/T variation in the human fibrinogen b promoter influences basal and IL-6 induced transcription and affects binding of nuclear proteins
	-	The long-term analytical performance of assay of anti-thrombin, protein C and protein
De Maeyer M.	-	An anti-idiotypic mouse monoclonal antibody towards idiotopes of human anti-C2 inhibitors mimics C2 the 3D conformation of C2 and restores Factor VIII activity in vivo
De Maistre E.	-	Increased thrombin potential due to acquired activated protein C resistance in patients with lupus anticoagulants
De Marco L.	-	Lagrangian modeling of platelet adhesion and its application to experimental data
	-	Crucial role of the ADP receptor P2Y1 in platelet adhesion and signaling under high flow
De Maria R.	-	Blood glutathione detects pro-oxidant patterns in mild hyperhomocysteinemia associated with atherothrombotic vascular events
De Mattei M.	-	The G>T point mutation (Val34Leu) in the Factor XIII-A subunit gene in venous leg ulcers
De Mazancourt P.	-	Two electrophoretic fibrinogen variants found in patients with normal coagulation and familial thrombosis
De Min A.	-	Occurrence of myocardial infarction and PAI-1 4G/5G and ACE I/D gene polymorphisms in patients on chronic dialysis
De Mitrio V.	-	Short-term effects of raloxifene on the main anti-coagulant systems in postmenopausal women
De Moerloose P.	-	Molecular analysis of factor XI deficiency in 8 Lebanese families: identification of two novel mutations
	-	Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism
De Moerloose P. H.	-	European forum on antiphospholipid antibodies standardization group: results of the 2nd round on antibeta2glycoprotein I home-made assays
De Moerloose PH.	-	Aspirin inhibits VCAM-1 expression induced by antiphospholipid antibodies
de Moerloose P.	-	Congenital afibrinogenemia: expression and analysis of novel mutations affecting fibrinogen assembly or secretion
De Moerloose P.	-	Effects of statins on adhesion molecules expression in endothelial cells
	-	Clinical usefulness of D-dimer according to clinical probability in patients with suspected pulmonary embolism
De Monte P.	-	A comparison between routine plasma INRs and fingerstick whole blood INRs determinations, using three portable self-testing devices (Coagucheck^®, Pro-Time^®, Gem-PLC^®) and a near-patient whole blood device (Thrombotrack^®)
	-	Management of oral anticoagulant therapy with Thrombotest^® using a whole blood testing device (Thrombotrack^®) in comparison to routine laboratory PT
De Monye W.	-	The role of spiral CT in alternative diagnosis in patients with clinical suspicion of pulmonary embolism
De Muret A.	-	Quantitative evaluation of TFPI-2 and MMP-9 expression in nonsmall cell lung cancer
De Nanteuil G.	-	Anti-thrombotic and anticoagulant effects of S35898 an orally active thrombin inhibitor
De Oña R.	-	Retrospective analysis of heritable thrombophilia in 90 children with Legg-Perthes disease
De Oña R.	-	Hypercoagulability in cerebrovascular disease (CD): factor V Leiden, prothrombin G20210A and MTHFR C677T mutations and polymorphism in the annexin V kozac sequence
	-	TNF-alpha promoter polymorphisms (-238 and -308) in patients with cerebrovascular disease
De Palma M.	-	The G>T point mutation (Val34Leu) in the Factor XIII-A subunit gene in venous leg ulcers
De Piano L. P. A.	-	Analysis of the effectiveness of the D-Dimer test to exclude acute venous thromboembolism
	-	Comparison of the point-of-care method for oral anti-coagulation control with the conventional method
De Prost D.	-	Fractalkine/CX3CL1 production by human aortic smooth muscle cells impairs monocyte procoagulant and inflammatory responses
	-	The Asp299Gly polymorphism of Toll-like receptor 4 as a genetic risk factor for acute coronary events
De Sá M. F. S.	-	Procoagulant effects of raloxifene in postmenopausal women
De Smedt E.	-	Exposure of procoagulant phospholipids in blood during exhaustive physical exercise
De Sousa M. A.	-	Inhibition of retinal neovascularization in mice by antisense phosphorodiamidate morpholino oligomer against a_v integrins
De Staercke C.	-	Comparison of cytokine-induced transcriptional factor response in HCAEC and HUVEC cell types
De Stefano V.	-	Risk for venous thrombosis in unusual sites associated with inherited thrombophilia: analysis of 133 patients
	-	Inherited thrombophilia and associated risk for unexplained fetal loss
	-	Risk for venous thromboembolism among younger or older carriers of inherited thrombophilia
	-	Risk for recurrent venous thromboembolism among patients with severe inherited thrombophilia
	-	Risk for recurrent venous thromboembolism after a first superficial vein thrombosis among carriers of inherited thrombophilia
De Stoer W.	-	Tissue factor (TF) and high-sensitivity CRP (HS-CRP) in patients with peripheral arterial disease (PAD) undergoing peripheral bypass surgery or angioplasty: a retrospective study
De Taeye B.	-	Importance of the mobility of the P' region for conformational and functional changes in PAI-1
de Veber G.	-	Very low dose warfarin for primary and secondary prophylaxis in children: a prospective cohort study of 20 children
	-	Reversal of warfarin or low molecular weight heparin (LMWH) using subcutaneous unfractionated heparin (UFH) in pediatric outpatients with an ongoing high risk for thrombosis and requiring invasive procedures: a prospective cohort study of 146 children
De Vicaris A.	-	Prolonged APTT children undergoing elective tonsillectomy
De Virgilio M.	-	The scaffold function of b3 integrins regulates integrin signaling
De Visser M. C. H.	-	Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci
De Vos R.	-	P2X₁-induced activation of Ca²⁺ calmodulin leads to myosin light chain and ERK2 phosphorylation in human platelets
De Vos A. F.	-	Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia
De Vos R.	-	Overexpression of the platelet P2X₁ ion channel in transgenic mice generates a novel prothrombotic phenotype
De Waard V.	-	Plasminogen activator inhibitor type I-deficient (PAI–/–) mice show an improved early host defense in E. coli peritonitis by a neutrophil-dependent mechanism
De Wilde R. B. P.	-	Evaluation of a bed-side device to assess the APTT for heparin monitoring in infants
De Winter R. J.	-	Recombinant truncated tissue factor triggers coagulation in normal human plasma via the extrinsic pathway
De Wit C.	-	Magnetofection – a highly efficient tool for endothelial gene transfer and antisense oligonucleotide delivery in vitro and in vivo
De Wolf C. J. F.	-	Tissue-specific regulation of protein S gene transcription
	-	C/EBP
Deam S.	-	Factor X Cardiff and Factor X Newcastle: Two new FX mutations associated with low activity and antigen levels
Dean W. L.	-	Integrin a₂b₁ stimulates platelet spreading through protein tyrosine phosphorylation and calcium mobilization
Dean W.	-	Translocation of plasma membrane Ca²⁺-ATPase to filopodia during platelet activation
Debili N.	-	Cross-talk between alpha2beta1 integrin and GPVI receptors regulates actin polymerization through Rho GTPase and MAP kinase Erk1/2 signaling pathways in human megakaryocytes
Debost M.	-	In vitro flow cytometry and functional testing of fresh and cryopreserved platelets
Debreceni I.	-	GPRP interferes with FXIIIa in localization to immobilized Fibrin(ogen) and with platelet deposition in different thrombosis models
Debusscher L.	-	Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool
Déchaud H.	-	Anti-protein Z antibodies in women with abnormal pregnancies
	-	Antiphospholipid/antiprotein antibodies and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case–control study
Dechavanne M.	-	Comparison of Clauss fibrinogen and fibrinogen measurement derived from aPTT and PT in diabetes mellitus and correlations with markers of glycemic equilibration
	-	Two electrophoretic fibrinogen variants found in patients with normal coagulation and familial thrombosis
DECISIONMATRIX TASKFORCE GROUP^*	-	Individualizing the risk of venous thromboembolism in medical and surgical patients: development of the decision matrix for VTE prophylaxis
Deckmyn H.	-	A new platelet activation marker specific for activated integrin alpha2beta1: monoclonal antibody IAC-1
	-	The platelet glycoprotein Ibalpha HPA-2 polymorphism affects VWF binding, but not thrombin interaction
	-	A new Von Willebrand ristocetin cofactor activity assay based on plasma glycocalicin
	-	Binding of minute amounts of thrombin to GPIbalpha accelerates early platelet reactions, but not the platelet procoagulant response
	-	GPRP interferes with FXIIIa in localization to immobilized Fibrin(ogen) and with platelet deposition in different thrombosis models
	-	The functional self association of von Willebrand factor is modulated by a multiple domain interaction
	-	Interplay of glycoprotein Iba, integrin a2b1 and glycoprotein VI is required for human thrombus formation under flow
	-	Identification of a novel inhibitory monoclonal antibody against the integrin a2b1
	-	Desaggregation of ristocetin-induced platelet aggregates by an inhibiting anti-GPIb MoAb
	-	Integrin activation upon human platelet adhesion to collagen under flow
Declerck P. J.	-	Importance of the mobility of the P' region for conformational and functional changes in PAI-1
	-	Characterization of monoclonal antibodies that inhibit either the activation of proCPU (TAFI) or the activity of CPU (TAFIa)
Decousus H.	-	Eight-year follow-up of a randomized trial investigating vena cava filters in the prevention of PE in patients presenting a proximal DVT: The PREPIC trial
Decousus H.	-	Risk factors of major hemorrhages during treatment of acute DVT: results from 5 randomized trials
	-	A meta-analysis on the benefit-to-risk ratio of Vitamin K antagonists (VKA) in the prevention of venous thromboembolism in major orthopedic surgery
	-	Predictive factors of cancer discovery after deep-vein thrombosis: a 8-years follow-up study
	-	Clinical experience with optional cava filters
	-	A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
	-	Factors predicting venous thrombotic complications after superficial–vein thrombosis
Décousus H.	-	Differences between predictive factors for PE and DVT recurrences: results from 5 randomized trials
Deddish R. B.	-	Heparin-induced anti-platelet antibodies in very low birth-weight infants
Dedja A.	-	Levels of anti-thrombin III activity in the plasma of cynomolgus monkeys after administration of recombinant human anti-thrombin III
Defaire U.	-	Prospective evaluation of t-PA/PAI-1 complex predicting myocardial infarction in controls included in the SHEEP study
Defilippis L.	-	Smoking and abnormalities of coagulation-fibrinolysis in patients with coronary heart disease
	-	Inflammatory factors in patients with acute coronary syndromes. Is there any fluctuation with smoking or cholesterol levels?
	-	Is there an hypercoagulable state after treadmill exercise in patients with atrial fibrillation?
Defiloppis L.	-	Obesity and coagulation. Is there any correlation?
Degen J. L.	-	A novel platelet-specific delivery system for fibrinolytic agents
Degerliyurt A.	-	Assessment of the role of various genetic risk factors in development of childhood cerebral thrombosis
DeGrado W. F.	-	Activation of the platelet integrin aIIbb3 by thermodynamic modulation of transmembrane helix associations
Deguchi H.	-	Synergy between deficiencies of plasma glucosylceramide and deficiency of activated protein C for venous thromboembolism
	-	Oral contraceptives decrease the sensitivity of plasma for the anticoagulant activity of activated protein C (APC) by decreasing plasma glucosylceramide (GlcCer) level
	-	Sphingosine and certain sphingolipid analogs are potent anticoagulants as prothrombinase inhibitors
Deguchi H.	-	Activated protein C anticoagulant activity mediated by phospholipid vesicles is enhanced by cholesterol and sphingomyelin
Deguzman F.	-	P2Y₁₂ regulates platelet adhesion/activation, thrombus growth and thrombus stability in injured arteries
Dehesdin D.	-	Thrombophilic risk factors and idiopathic sudden sensorineural hearing loss
Dehmer T.	-	Long-term RAGE-mediated NF-kB activation in diabetic neuropathy and its role in loss of pain perception
Deinum J.	-	Characterization of the interaction of alpha-thrombin with melagatran analogs with different P3 substituents: a kinetic and thermodynamic study
Deitcher S. R.	-	Secondary prevention of venous thromboembolic events (VTE) in patients with active malignancy: a randomized study of enoxaparin sodium alone vs. initial enoxaparin sodium followed by warfarin for a 180-day period
Deitcher S. R.	-	Malignancy-related thrombotic state is independent of defects in Factor V Leiden, prothrombin 20210 and MTHFR. Results from the initial profiling of cancer patients entering in a secondary prevention of venous thrombosis with enoxaparin (ONCENOX)
Del Ben M.	-	Fibrinogen as predictor of ischemic stroke in patients with nonvalvular atrial fibrillation
Del Boccio P.	-	Pharmacological and cellular bases of some anti-thrombotic properties of extravirgin olive oil: studies on oleuropein and hydroxytyrosol
Del Fabro V.	-	Desmopressin subcutaneous administration enhances platelet response ‘in vivo’ to Platelet-Activating Factor (PAF) and causes a rise in interleukin-6 plasma levels in haemophilia A and von Willebrand disease type I
Del Giglio A.	-	Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis
Del Soldato P.	-	LPS induced MMPs release in mice: role of platelets and inhibition by NCX4016 (nitroaspirin)
Del Turco S.	-	At least two distinct pathways generating reactive oxygen species mediate endothelial VCAM-1 induction by advanced glycation endproducts
Dela Cadena R. A.	-	Connective tissue growth factor (CTGF) expression in synovial lining is down regulated by residues D793-P824 derived from thrombospondin-1 type-3 repeats (TSP1) in an experimental animal model of rheumatoid arthritis
Delabar J. M.	-	Effect of hyperhomocysteinemia on paraoxonase activity
Delahousse B.	-	G20210A prothrombin gene mutation appears as the most important inherited prothrombotic risk factor in ‘idiopathic’ portal vein thrombosis
	-	Inherited risk factors are different in pregnant and nonpregnant women with venous thromboembolism
	-	Frequency of platelet glycoproteins alpha2807T and GPIbalpha Kozak polymorphisms in central retinal vein occlusion
	-	Multicenter evaluation of a new polymer tube (Vacuette Sandwich) for coagulation testing. Effect on routine coagulation tests and on plasma levels of markers of coagulation activation
Delaney S.	-	Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis
Delaney S. M.	-	The platelet ADP receptor P2Y₁₂ is a critical player on the pathway of aIIbb3 activation by multiple agonists
Delaney S. M.	-	P2Y₁₂ regulates platelet adhesion/activation, thrombus growth and thrombus stability in injured arteries
Delaunoit C.	-	Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool
Delgado-Alves J.	-	Pro-atherogenic role for IgG antioxidised-low-density-lipoprotein-beta-2-glycoprotein-I complex in primary antiphospholipid syndrome
	-	Elevated plasma factor XIII relates to intima media thickness of carotid arteries in primary antiphospholipid syndrome
DELL'Elba G.	-	Injection of the inflammatory peptide fMLP in the rabbit induces transient myocardial ischemia: role of thromboxane A2
Dell'elba G.	-	Are daily doses of 80 and 160 mg of aspirin bioequivalent? A pharmacokinetic and pharmacodynamic approach
Delmas E.	-	The protective effect of estradiol is dependent on immune system for spontaneous atherosclerosis but not for injury-induced atherosclerosis
Demarmels Biasiutti F.	-	Splenectomy in relapsing and plasma-refractory thrombotic thrombocytopenic purpura
Dembinska-Kiec A.	-	Biochemical fibrinogen modification and atherogenesis
Dembinska-Kiec A.	-	Regulation of gene expression in huvec and human umbilical progenitor CD 34⁺ cells by VEGF, bFGF and PPARg agonist
Dembinska-Kiec A.	-	Sialic acid and lipid contents of low density lipoprotein in relation to platelet receptor activity
Demers C.	-	Asymptomatic venous thrombosis is a frequent event in protein C deficiency: a systematic ultrasound assessment of 208 family members with the 3363-C insertion mutation (IPCI: International Protein C Investigation)
	-	Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
	-	Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
Demeulemeester D.	-	Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice
Demian S.	-	Use of recombinant activated factor VII (NovoSeven) in patients with liver cirrhosis
Demiguel V.	-	Effect of type of treatment (recombinant vs. plasmatic) on FVIII inhibitor incidence according to known risk cofactors in previously untreated severe hemophilia A patients (Pups)
Demir M.	-	The irrelevance of International Normalized Ratio in the monitoring of anti-IIa and anti-Xa drugs
Demir M.	-	Fibrinopeptide-A generation inhibition by anti-Xa drugs and its correlation with activated clotting time
Deml M.	-	Factor XIII Val34Leu polymorphism in pediatric thrombophilia evaluation: is there clinical relevance?
Demoulin M. L.	-	Age influence on D-Dimer in a large normal French population: the FITENAT study
Demuth D.	-	Effect of hyperhomocysteinemia on paraoxonase activity
Den Heijer M.	-	Elevated plasma cysteine concentration as a risk factor for venous thrombosis
	-	Influence of vitamin supplementation on homocysteine and cysteine concentrations in blood
Den Heijer M.	-	Homocysteine lowering by B vitamins and the prevention of secondary deep-vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial
	-	Hyperhomocysteinemia: risk factor or consequence of venous thrombosis?
Den Heijer M.	-	Effect of the methionine synthase reductase A66G polymorphism on total homocysteine levels and venous thrombosis risk
Den Heijer M.	-	Effects of genes and environmental factors on homocysteine level
Den Heijer M.	-	Venous outflow resistance can be used after acute deep-vein thrombosis as a screening test to identify patients at risk of the post-trombotic syndrome
	-	Compression bandaging in the acute phase of deep-vein thrombosis reduces symptoms but does not decrease venous outflow resistance and thrombosisscore as a proxy of the post-trombotic syndrome
	-	Contribution of genetic factors to mild hyperhomocysteinemia
	-	IL-6 concentration in the acute phase of deep-vein thrombosis is a strong predictor of elevated venous outflow resistance as a proxy of post-trombotic syndrome
	-	Homocysteine concentrations are associated with increased t-PA and PAI concentrations in smokers
	-	Is isolated postmethionine-load hyperhomocysteinemia a separate risk factor for venous thrombosis?
Deng G. G.	-	Overexpression of PAI-1 prevents abdominal aortic aneurysm development
Denis C. V.	-	An in vivo model to study von Willebrand factor (VWF) clearance: fundamental aspects and application to the Arg1205His Vicenza mutation
	-	Increased metastatic potential of tumor cells in von Willebrand factor (VWF)-deficient mice
Dennis M.	-	The prothrombinase enhancing activity exhibited by VLDL derived from patients with the biphasic APTT waveform is due to increased anionic phospholipid exposure
Denoyelle C.	-	Human endothelial cells synthesize Protein Z
Dent J.	-	Platelet septins and enhanced platelet function in SEPT5-deficient platelets
Dentali F.	-	Determinants of delayed thrombus regression after deep vein thrombosis of the lower limbs: a prospective cohort study
	-	Weight changes after acute deep venous throbosis: a prospective observational study
	-	Early developments of the post-thrombotic syndrome in overweight and obese patients
Denter M.	-	Why did rFVIIa have no effect in post delivery bleeding? – a case-report
Denti L.	-	Diagnosis of deep vein thrombosis in hospitalized elderly patients: poor discriminant value of clinical pretest probability unless integrated by d-dimer assay
Deol P.	-	The effects of folic acid supplements on coagulation status in pregnancy
Depalma R. G.	-	Reducing body iron stores lowers inflammatory cytokine levels in atherosclerotic claudicants
Depasse F.	-	Effect of rFVIIa (NovSeven^®) on thrombin generation in patients with severe thrombocytopenia
Depasse F.	-	Measurement of synthetic pentasaccharide fondaparinux (arixtra) anti-Xa activity
Depasse F.	-	The role of tissue factor on the inhibition of prothrombin activation and thrombin generation by the synthetic pentasaccharide (fondaparinux)
	-	The role of tissue factor on the inhibition of prothrombin activation and thrombin generation by the synthetic pentasaccharide (fondaparinux)
D'Ercole C.	-	Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth retardation
Dereume J. P.	-	Phenotype of T cells in human abdominal aortic aneurysm
Derksen R. H. W. M.	-	The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasma
	-	IgG isolated from plasmas of patients with the anti-phospholipid syndrome binds to domain I of beta2-glycoprotein I
	-	Dimers of b2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2: an explanation for arterial thrombosis in the anti-phospholipid syndrome
	-	Dimerization of beta2-glycoprotein I is necessary for binding to and activation of endothelial cells
	-	Binding of b2-glycoprotein I and dimeric b2-glycoprotein I to members of the low-density lipoprotein receptor superfamily: implications for the anti-phospholipid syndrome
Dermitzakis A.	-	Levels of plasma tissue activator plasminogen (tPA)- A useful marker in the differential diagnosis of chest pain (marker of plaque destabilization)
	-	Correlation between SVCAM, SICAM plasma levels, the outcome of treadmill test and the systolic function of left ventricular (LV) in patients with coronary artery disease
	-	Correlation SVCAM, SICAM plasma levels with the outcome of treadmill test and with attitudinal factors for coronary artery disease in patients without previous history of ischemic heart disease
	-	Inflammatory factors in patients with acute coronary syndromes. Is there any fluctuation with smoking or cholesterol levels?
Derrick J. M.	-	The peptide LSARLAF directly induces a conformation change in the platelet integrin aIIbb3
Desai U.	-	Anti-thrombin III phenylalanines 122 and 121 contribute to its high affinity for heparin and conformational activation
Desai H.	-	Functional anti-heparin-PF4 antibody-mediated platelet–endothelial cell interactions: modulation of tissue factor activity involved in the HIT pathogenesis
	-	Tissue factor is present in platelet-derived microparticles from healthy donors
	-	Platelet purified vascular endothelial growth factor-165 enhances tumor cell tissue factor expression and procoagulant activity
	-	Platelet microparticles carry CD40 ligand and up-regulate TF and VEGF in endothelial and melanoma cells: possible role in angiogenesis and metastasis
	-	Platelet CD40L and CD40 enhance tumor cell-induced coagulopathy and experimental metastasis
Descals E.	-	Changes in thromboelastography in low-risk women in the puerperium
Deschamps A.	-	Normal values of total and free TFPI levels in the newborn and in children
Deschepper N.	-	A new Global Plasma Fibrinolytic Assay for the rapid analysis of hyper-/hypo-Fibrinolysis: relationship with blood lipids and inflammatory markers
	-	The biphasic waveform of APTT optical clot formation profile is related with the activation of FVII but not with ISTH DIC score or classical coagulation activation parameters
Desjardins L.	-	Resource utilization and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis
Desmarais S.	-	Resource utilization and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis
Desouza P.	-	Thrombotic potential may be increased in healthy individuals with a two-generation family history of premature myocardial infarction
Desouza A.	-	A patient with factor V Leiden who rapidly developed fatal heparin induced thrombocytopenia
Desprez D.	-	Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth retardation
Deterre P.	-	Fractalkine/CX3CL1 production by human aortic smooth muscle cells impairs monocyte procoagulant and inflammatory responses
Deveber G.	-	Low molecular weight heparin therapy in neonatal cerebral sinovenous thrombosis: a consecutive cohort study
Deveber G.	-	Frequency and predictors of vaso-occlusive strokes associated with cardiac surgery in infants and children with congenital heart disease
	-	Venous thrombosis in children
Deveber G.	-	Predictors of recurrent thrombo-embolic events in 153 infants and children with cerebral sinovenous thrombosis: a national population based study
Devecioglu O.	-	A single dose (0.8 g kg) of intravenous immunoglobulin in children with acute immune thrombocytopenic purpura
Devenie G.	-	Correction of coagulation, as measured by the thromboelastogram, with low dose recombinant VIIa treatment in a patient with a factor VIII inhibitor
Devi G. R.	-	Inhibition of retinal neovascularization in mice by antisense phosphorodiamidate morpholino oligomer against a_v integrins
Devictor D.	-	Fatal intra cerebral hemorrhage due to severe vitamin K deficiency disclosing cystic fibrosis
Devoto E.	-	Blood glutathione detects pro-oxidant patterns in mild hyperhomocysteinemia associated with atherothrombotic vascular events
DeVriese A.	-	Endothelial-specific inactivation of survivin in mice results in embryonic lethality with intraembryonic bleeding due to loss of vascular endothelial integrity
Devulder B.	-	Interest of diluted Russel viper venom time (dRVVT) in determining “pathogenic” lupus anticoagulants
Devy L.	-	Plasminogen activator inhibitor PAI-1 as a regulator of urokinase in angiogenesis
Dew R.B.†	-	The effect of drotrecogin alfa (Xigris) on the biphasic PTT waveform in patients with sepsis
Dewar L.	-	Altered regulation of in vivo coagulation in orthopedic patients prior to knee or hip replacement surgery
Dewerchin M.	-	Effect of anticoagulants with various modes of action on thrombin generation in plasma of mice with targeted Arg47-to-Cys mutation of the heparin-binding domain of antithrombin
Dewilde M.	-	Importance of the mobility of the P' region for conformational and functional changes in PAI-1
DGTI STUDY GROUP‡	-	Multicenter study of the DGTI: factor VIII determination of FVIII products with a chromogenic method^®
Di Castelnuovo A.	-	NAD(P)H oxidase C242T gene variations and cardiovascular protection
	-	Polymorphisms of the interleukin 1-b gene, inflammatory and hemostatic response and the risk of premature myocardial infarction
	-	Are daily doses of 80 and 160 mg of aspirin bioequivalent? A pharmacokinetic and pharmacodynamic approach
	-	Hyperhomocysteinemia is associated with the progression of peripheral arterial disease in type 2 diabetic patients
Di Deo A.	-	Pharmacological and cellular bases of some anti-thrombotic properties of extravirgin olive oil: studies on oleuropein and hydroxytyrosol
Di Falco G.	-	Management of oral anticoagulant therapy in the perioperative period: preliminary results of the application of an operative protocol
Di Francesco E.	-	Sickle cell disease, vascular endothelium dysfunction, abnormal endothelin-1 release, interleukin-6 plasma level, hyperhomocysteinaemia and thromboembolic risk
	-	Desmopressin subcutaneous administration enhances platelet response ‘in vivo’ to Platelet-Activating Factor (PAF) and causes a rise in interleukin-6 plasma levels in haemophilia A and von Willebrand disease type I
	-	The platelet glycoprotein IIb/IIIa receptor antagonist c7E3Fab inhibits the coagualation activation in patients undergoing to percutaneous transluminal coronary angioplasty (PCTA)
Di Lecce V. N.	-	Fibrinogen as predictor of ischemic stroke in patients with nonvalvular atrial fibrillation
Di Micco P.	-	Increased intima-media thickness to show relationship between atherosclerosis and inflammation in a human model: patients affected by rheumatoid arthritis and absence of common markers of atherosclerosis
Di Minno G.	-	Prevalence of haemostatic abnormalities in women with 3 or more implantation failures after in vitro fertilization
	-	Women with common prothrombotic mutations are not at higher risk of recurrent intrauterine fetal deaths
Di Napoli P.	-	Inhibition of 3-Hydroxy-3-methylglutaryl coenzyme-A reductase attenuates expression of inducible nitric oxide synthase in cardiac myoblasts – Possible link to direct myocardial protection during ischemia-reperfusion
Di Nisio M.	-	Clopidogrel suppresses rebound coagulation after discontinuation of enoxaparin treatment in patients with acute coronary syndromes
Di Paola J.	-	Role of the FcR gamma chain in collagen-induced platelet procoagulant activity
Di Santo A.	-	Tissue factor expression by human endothilial cells is down-regulated by antagonists of the renin-angiotensin system
Di Santo A.	-	Resveratol and quercetin inhibit tissue factor expression in vascular cells by preventing IkappaBalpha degradation and c-Rel/p65 activation
Di Somma C.	-	A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter
Di Tommaso R.	-	Resveratol and quercetin inhibit tissue factor expression in vascular cells by preventing IkappaBalpha degradation and c-Rel/p65 activation
Diacovo T.	-	Kinetic analysis of mutations associated with a platelet adhesion receptor or its ligand reveals similarities between the genetically distinct bleeding disorders known as PT- and type 2B vWD
Diamant M.	-	Subpopulations of tissue factor-exposing microparticles from platelets and T-cells colocalize leukocytic antigens in uncomplicated human type 2 diabetes
Diamond S.	-	Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow by activating fibrinogen-adherent platelets
Diamond S. L.	-	Kinetic analysis of mutations associated with a platelet adhesion receptor or its ligand reveals similarities between the genetically distinct bleeding disorders known as PT- and type 2B vWD
Diamond S. L.	-	Adhesion of normal erythrocytes at depressed venous shear rates to activated neutrophils, activated platelets, and fibrin polymerized from plasma
Dias M.	-	rFVIIa (Novoseven^®) in the treatment of Glanzmann's Thrombastenia
	-	Treatment of acquired factor VIII inhibitor using Feiba and Prednisone
Díaz A.	-	Retrospective study of acquired factor VIII inhibitor
Diaz A.	-	Association between recurrent pregnancy loss and prothrombotic gene polymorphisms
Díaz-Ricart M.	-	Effect of antiphospholipid antibodies in the activation of the contact complex: importance in the obstetric complications of the antipospholipid syndrome
Diaz-Ricart M.	-	Granulocyte colony-stimulating factor exerts a pro-inflammatory effect on endothelial cells through activation of p38 MAPK
Dichek D.	-	Modulation of uPA activity and neointima formation by gene transfer
Dick E.	-	Elevated coagulation factors in rabbits (Oryctolagus cunniculus) following brown recluse envenomation (Loxoceles reclusa)
Dick A.	-	Improved differentiation between factor V wild type and factor V Leiden patients using a new prothrombin-based activated protein C resistance assay
	-	The German thrombophilia-registry – first results: Women specific risk factors and venous thrombosis
Dickneite G.	-	FXIII promotes endothelial cell migration, proliferation, and inhibits apoptosis
Dier K. J.	-	IgG antiphosphatidylserine and anti-b2GPI are better predictors of arterial and venous thrombosis than anticardiolipin antibodies in antiphospholipid syndrome
Dietrich-Neto F.	-	Prolonged prophylaxis against VTE with enoxaparin in patients undergoing surgery for malignancy: 1-year survival study
	-	Efficacy and safety of once-daily Enoxaparin given in the outpatient setting compared with in-hospital unfractionated heparin for treatment of proximal lower limb deep-vein thrombosis
	-	Cost analysis of the treatment of patients with post–thrombotic syndrome in Brazil
Díez J.	-	Circulating prostaglandin E2 is associated with high risk of coronary heart disease in asymptomatic subjects: a novel inflammatory marker of subclinical atherosclerosis
Diez Campelo M.	-	Massive life-threatening lung hemorrhage and successful treatment with recombinant human-activated FVIIa concentrates
Dignat George F.	-	Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration
Dignat-George F.	-	Evaluation of aspirin resistance by platelet function analyzer (PFA-100™) in patients with acute coronary syndrome^®
Dignat-George F.	-	Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth retardation
Dignat-George F.	-	Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth retardation
	-	Interest of VASP measurement on patients treated by thienopyridines
	-	Activation of p38 MAPK promotes an endothelial adhesive phenotype in response to anti-phospholipid antibodies
Dikkeschei L. D.	-	Performance evaluation of the new CoaguChek^® PT.S-test on the CoaguChek^® S system
Dill J. L.	-	Evidence that interaction of the A2 domain of factor VIIIa with factor IXa occurs over an extended surface
Dilley A.	-	Relationship of the Val34Leu polymorphism in the factor XIII gene with venous thromboembolism in American whites and blacks: the GATE study
	-	The relationship between the TNF-308 polymorphism and Legg-Perthes disease
	-	Association of plasma homocysteine, serum folate, and red-blood cell folate with venous thromboembolism in American whites and blacks: the GATE study
	-	Treatment and management of women with bleeding disorders and menorrhagia (WBDM) study: study design and characteristics of women enrolled
Dillon R.	-	Molecular dissection of the human TAFI promoter
Dillon I. M.	-	Comparative response of plasma VWF in normal and von Willebrand disease dogs to up-regulation of VWF mRNA by Interleukin-11 vs. Weibel–Palade body release by Desmopressin (DDAVP)
Dimichele D.	-	Alternate day immune tolerance regimen in severe hemophilia A with high titer inhibitors: a single center's experience
	-	Novel factor V mutations in three separate families resulting in factor V deficiency and bleeding
Diminno G.	-	Polymorphisms in the thrombomodulin gene as risk factors for myocardial infarction (HIFMECH study)
Dimitrova Y.	-	Effects of statins on adhesion molecules expression in endothelial cells
Dimmeler S.	-	Stem cell mobilization and differentiation to endothelial cells
D'Incà M.	-	Hyperhomocysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease
Ding K.	-	Increased fibronectin secretion but not cell surface expression in thrombin-activated platelets of hypofibrinogenemia patients
Ding Z.	-	Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, C17 and C270
Dinger R.	-	Development of a biosensor system for self-testing the intensity of anti-coagulation by anti-coagulated patients in capillary whole blood
Dinis-Ribeiro M.	-	A different view on the inflammatory bowel disease – the role of adhesion molecules and angiogenic growth factors
Diniz M. J.	-	rFVIIa (Novoseven^®) in the treatment of Glanzmann's Thrombastenia
	-	Treatment of acquired factor VIII inhibitor using Feiba and Prednisone
Dinyari M.	-	A pharmacokinetic study of tinzaparin in pediatric patients
	-	Ex vivo thrombin generation capacity in pediatric patients receiving Tinzaparin
	-	A dose-finding study of Tinzaparin in pediatric patients
Diprose P.	-	Residual platelet function can be detected in patients on antiplatelet therapy using novel Hemoscope reagents and standard Thrombelastograph^® (TEG^®)
Dirat G.	-	Efficacy and safety of the first nanofiltered plasma-derived FVIII (FACTANE®) in previously treated haemophilia A patients
Dirven R. J.	-	Characterization of an immunologic polymorphism in the heavy chain of human factor V, due to a dimorphism of residue 79
Dirven R.	-	Activated factor V is inactivated by activated protein C in the absence of APC cleavage sites at Arg306, Arg506 and Arg679
Distante A.	-	Statins inhibit cyclo-oxygenase (cox)-2 and metalloproteinase (mmp)-9 expression in human endothelial cells: possible contribution to plaque stability
dit Bal C.	-	Age influence on D-Dimer in a large normal French population: the FITENAT study
dit Bal Sollier C.	-	A comparative pharmacodynamic study of anti-Xa activity to evaluate the accumulation effect of Tinzaparin and Enoxaparin given at prophylactic dose over 8 days in elderly patients with impaired renal function
Dix D. B.	-	An assessment of the appropriateness of published pediatric dosage guidelines for low molecular weight heparin (Enoxaparin) in a tertiary care institution
Dixon J. L.	-	The high frequency and specificity of the Lupus cofactor effect in a dPT screen
Djamiatun K.	-	Endothelial cell and monocyte-derived microparticles in severe dengue virus infections
Djanani A.	-	Expression of endothelial protein C receptor by human neutrophils and its role in cell migration
Djordjevic V.	-	The FV Leiden, FII G20210A and MTHFR C677T mutations in healthy and thrombophilic Yugoslav population
Djunaedi H.	-	The bedside investigation of pulmonary embolism diagnosis (BIOPED) study- a triple blind randomized control trial comparing initial bedside diagnostic tests to standard care (initial V/Q scan) in the investigation of patients with suspected PE
Djuric D. M.	-	Platelets–coronary endothelium interaction: focus on L-arginine:NO system
Dkhissi F.	-	The anti-angiogenic effect of endostatin is associated to a direct effect on the tumor growth in colon cancer
Dlott J. S.	-	The high frequency and specificity of the Lupus cofactor effect in a dPT screen
Doðan Ö.	-	Alpha-fibrinogen Thr 312 Ala polymorphism in Turkish population
Dobaczewski G.	-	Recombinant activated coagulation factor VII for the treatment of spontaneous bleeding in a girl with inhibitors developed after autologus bone marrow transplantation
Dobao M. L.	-	Temporary discontinuation of oral anti-coagulants in oncologic patients with mechanical heart valves
Dobrovolksy A.	-	The effect of clopidogrel on walking distance and hemostasis in patients with intermittent claudication
Dobrovolna M.	-	A human factor VIII inhibitor tolerating the endogenous FVIII with a unique A2 domain substitution in CRM + hemophilia A
Dobrovolsky A.	-	The influence of exercise and stress on markers of activation of coagulation and fibrinolysis in young postinfarction patients
	-	Efficacy of 1-year acenocumarol therapy and its relation with gene polymorphism related to thrombophilia in patients with nonvalvular atrial fibrillation
	-	The influence of treatment with low molecular weight heparins (dalteparin, nadroparin) on the clinical course and hemostasis activation markers in patients with unstable angina
Dobrovolsky A. B.	-	Clopidogrel in non-ST-elevation acute coronary syndrome: effect on parameters of fibrinolysis and blood coagulation
Dobrynina L.	-	Factor V Leiden, prothrombin G20210A, and MTHFR C677T gene mutations in patients with primary anti-phospholipid syndrome and cerebrovascular disorder
Dockal M.	-	Surface exposed mutation W2313A in the C2-domain of FVIII results in defective secretion of otherwise functional protein
Dodds M. G.	-	Pharmacokinetics of recombinant human FXIII in cynomolgus monkeys
Dodge S.	-	Unexpected pattern of hypercoagulable states in patients with patent foramen ovale (PFO) or atrial septal defect (ASD) and neurological events
Dodt J.	-	Mechanisms involved in the differential regulation of endothelial cells and lung fibroblasts by the hyaluronan-binding protease
	-	Intracellular signaling in human endothelial cells induced by the hyaluronan-binding protease
Doering C. B.	-	Characterization of high level expression sequence determinants within porcine factor VIII
Doermann D.	-	Labrirhagin, a protein with metalloprotease and disintegrin domains from Trimeresurus albolabris venom, activates platelets by a mechanism involving GPVI, aIIbbIII3
Doggen C. J. M.	-	Post-thrombotic complaints are not related to factor V Leiden mutation or elastic compression stockings: results of the MEGA Study
	-	Risk of venous thrombosis for patients with various malignancies and with factor V Leiden or the prothrombin 20210 A mutation: the MEGA case–control study
	-	The thrombotic risk of different types of oral contraceptives and interaction with factor V Leiden and the prothrombin 20210 A mutation: results of the MEGA study
	-	Screening for annexin A5 gene mutations and the risk of the C-1T mutation in venous thrombosis and myocardial infarction
Doggett T. A.	-	Kinetic analysis of mutations associated with a platelet adhesion receptor or its ligand reveals similarities between the genetically distinct bleeding disorders known as PT- and type 2B vWD
Dohmae N.	-	Purification and identification of coagulation factor IX-activating enzyme on the erythrocyte membranes
D'Oiron R.	-	Deletion of residue Ala2201 in the factor VIII C2 domain impairs FVIII interactions with phospholipids and vWF and results in mild hemophilia A
D'Oiron R.	-	Response to DDAVP in mild/moderate hemophilia A patients according to the underlying factor VIII genotype
D'Oiron R.	-	Identification and expression of the first type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene
Dokou E.	-	Is the G455A polymorphism of the fibrinogen beta gene associated with osteonecrosis? A preliminary report
	-	Mutations of the methylenetetrahydrofolate reductase (MTHFR) gene and osteonecrosis. A preliminary report
Dolan G.	-	Evaluation of the role of genetic analysis in dysfibrinogenemia
Dolan S.	-	A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer
	-	Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
Dolan G.	-	Factor X Cardiff and Factor X Newcastle: Two new FX mutations associated with low activity and antigen levels
Dolce A.	-	Chemotherapy-induced activation of hemostasis: the role of d-dimer
Dole W. P.	-	Overexpression of PAI-1 prevents abdominal aortic aneurysm development
Dolgushina N. V.	-	Prophylaxis of main obstetric complications in pregnant women with anti-phospholipid syndrome and genetic forms of thrombophilia
Dolgushina N.	-	The role of herpetic infections in genesis of endothelial damage in pregnant women with fetal loss syndrome
Dolgushina N. V.	-	A case of pregnancy and labor management in patient with recurrent thromboses and multigenic thrombophilia
	-	A case of catastrophic anti-phospholipid syndrome in pregnant woman with eclampsia
Domagala T. B.	-	Immediate anti-coagulant and anti-inflammatory effects of simvastatin and fenofibrate in patients with coronary artery disease
Domagala T.	-	Thrombin generation in response to methionine loading test in patients with ischemic heart disease
Domènech P.	-	PROS1 mutations that introduce a premature termination codon explain protein S deficiency by nonsense-mediated mRNA decay
Domi T.	-	Frequency and predictors of vaso-occlusive strokes associated with cardiac surgery in infants and children with congenital heart disease
Domínguez H.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Dominguez C.	-	Treatment of acquired factor VIII inhibitor using Feiba and Prednisone
	-	rFVIIa (Novoseven^®) in the treatment of Glanzmann's Thrombastenia
Dominguez H.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Domínguez M. P.	-	Behaviour of the protein C (PC)/protein S (PS) ratio in patients with thrombosis
Domm J. A.	-	Utility of PFA-100 in pediatric patients referred for evaluation of bleeding symptoms
Donaldson K.	-	Procoagulant changes in human macrophages induced by environmental microparticles [PM₁₀]: a possible pathogenetic mechanism in cardiovascular disease
Donat F.	-	Two sensitive chromogenic assays of fondaparinux sodium (Arixtra^®), a new synthetic and selective inhibitor of factor Xa, in plasma
Donati M. B.	-	Pharmacological and cellular bases of some anti-thrombotic properties of extravirgin olive oil: studies on oleuropein and hydroxytyrosol
	-	Resveratol and quercetin inhibit tissue factor expression in vascular cells by preventing IkappaBalpha degradation and c-Rel/p65 activation
	-	Tissue factor expression by human endothilial cells is down-regulated by antagonists of the renin-angiotensin system
	-	Effect of extra virgin olive oil on experimental thrombosis and primary haemostasis in rats
	-	Polymorphisms of the interleukin 1-b gene, inflammatory and hemostatic response and the risk of premature myocardial infarction
	-	Hyperhomocysteinemia is associated with the progression of peripheral arterial disease in type 2 diabetic patients
Dong J. C.	-	Anticoagulant heparan sulfate proteoglycans in mammalian reproductive function
Dong J.-F.	-	Peptides from the C-terminal regions of ADAMTS-13 specifically block cleavage of ultra-large von Willebrand factor multimers on the endothelial surface under flow
Dong N.	-	Activated thrombin–activatable fibrinolysis inhibitor (TAFIa) prevents spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs
Donush E. K.	-	The principles of therapy of hemorrhagic vasculitis at children
	-	Using NovoSeven (NS) – recombinant factor VIIa to control the bleedings in Bernard-Soulier (BSS) girl. Case report
Donzelli M.	-	Coagulation and complement inhibitors levels predict outcome in patients with severe sepsis
Dooley M.	-	Evaluating 'aspirin resistance' in a population with cardiovascular disease
Dooley M.	-	The choice of assay, agonist and anticoagulant for determining efficacy of GPIIb/IIIa antagonists
Doolittle R. F.	-	Structure of fibrinogen
Dopheide S. M.	-	Mechanotransduction through glycoprotein Iba induces a unique series of morphologic changes in translocating platelets
Dorado G.	-	A promising therapeutic strategy in acute promyelocytic leukemia (APL): disruption of MEK/ERK, arsenic and retinoids
	-	Increased tissue factor expression in monocytes from patients with anti-phospholipid syndrome depends on NFkB activation
D'Orazio A.	-	Risk for recurrent venous thromboembolism after a first superficial vein thrombosis among carriers of inherited thrombophilia
	-	Polymorphisms of the interleukin 1-b gene, inflammatory and hemostatic response and the risk of premature myocardial infarction
	-	Risk for venous thrombosis in unusual sites associated with inherited thrombophilia: analysis of 133 patients
	-	Inherited thrombophilia and associated risk for unexplained fetal loss
	-	Risk for venous thromboembolism among younger or older carriers of inherited thrombophilia
Dörffler-Melly J.	-	Tissue factor (TF) and high-sensitivity CRP (HS-CRP) in patients with peripheral arterial disease (PAD) undergoing peripheral bypass surgery or angioplasty: a retrospective study
Dorfleutner A.	-	Specificity of coagulation factor signaling
Doria S.	-	Venice DVT
Dorling A.	-	Targeted expression of tissue factor pathway inhibitor and hirudin fusion proteins to endothelial cells reduces pathology in murine LPS-induced endotoxic shock – a novel model to study vascular inflammation
	-	Expression of human tissue factor pathway inhibitor and hirudin fusion proteins on mouse vascular smooth muscle cells inhibits vascular remodeling after wire-induced carotid artery injury
Dorner F.	-	Surface exposed mutation W2313A in the C2-domain of FVIII results in defective secretion of otherwise functional protein
	-	Development of an advanced category recombinant FVIII, anti-hemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM)
	-	Differentiation of factor VIII-specific memory B cells into anti-factor VIII antibody-secreting cells requires direct interaction between memory B cells and activated T cells but is not dependent on factor VIII-specific T cells
Dorsam R. T.	-	Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, C17 and C270
Dorward N.	-	The suitability of various evacuated blood collection tubes for monitoring heparin
Dorward N. R.	-	Comparison of normal values for coagulation measurements in a variety of evacuated containers
	-	A comparison of various evacuated blood collection tubes for monitoring warfarin therapy with Innovin
Doskocz R. E.	-	Alpha 1-anti-trypsin concentration and atheromatosis risk factors in patients with abdominal aorta aneurysmata
Doskocz R. E.	-	Anti-oxidized LDL antibodies in patients with abdominal aorta aneurysm and arteriosclerosis obliterans
Dossenbach-Glaninger A.	-	Recurrent pregnancy loss between the 8th and 15th week of gestation is not associated with an increased frequency of protein Z deficiency
Dotsenko O.	-	Coagulation, fibrinolysis and platelet activity in aspirin-naive and prior aspirin users unstable angina patients, treated with unfractionated heparin
Dotsenko O. R.	-	Coagulation, fibrinolysis and platelet activity in aspirin-naive and prior aspirin users unstable angina patients, treated with unfractionated heparin
Dotti C.	-	High levels of factors VIII, IX and XI in patients with a thromboembolic event
Dou L.	-	The uremic retention solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair in vitro
Doubine S.	-	Maintenance doses of lepirudin (Refludan), as adjusted by a chromogenic substrate assay (CSA), highly suggest that recommended therapeutical doses should be safely reduced
Douketis J.	-	Low-molecular-weight heparin (LMWH) as bridging anticoagulation in patients who require temporary interruption of warfarin for elective surgery: assessment of a standardized perioperative anticoagulation regimen
Douketis J. D.	-	Brain natriuretic peptide (BNP) as a predictor of adverse outcome in patients with pulmonary embolism
	-	Patients receiving long-term warfarin therapy prefer INR testing with capillary fingerstick over venous blood testing
Douketis J.	-	Ability of d-dimer to reduce the need for diagnostic imaging in patients with suspected pulmonary embolism: A randomized trial
Douketis J.	-	The prevalence and prognostic importance of elevated cardiac troponins in patients with acute submassive pulmonary embolism
Douketis J.	-	Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
Douketis D.	-	A dose–response study of a recombinant human soluble thrombomodulin (ART-123) for prevention of venous thromboembolism after unilateral total hip replacement
Douketris J. D.	-	d-dimer as a prognostic marker in patients with pulmonary embolism
Dovlatova N. L.	-	Leukocyte–platelet interaction: modulation by lipids of different density and inhibition by high dose of catecholamines
Dovlatova N. L.	-	Platelet activity and circulating leukocyte-platelet aggregates can be markers of thrombotic and inflammatory processes in patients with coronary atherosclerosis
Dowling N. F.	-	The relationship between genetic variants in peroxisome proliferator-activated receptors and venous thromboembolism in African-Americans and Caucasians
Dowling N. F.	-	Relationship of the Val34Leu polymorphism in the factor XIII gene with venous thromboembolism in American whites and blacks: the GATE study
	-	Association of plasma homocysteine, serum folate, and red-blood cell folate with venous thromboembolism in American whites and blacks: the GATE study
Downey C.	-	The prothrombinase enhancing activity exhibited by VLDL derived from patients with the biphasic APTT waveform is due to increased anionic phospholipid exposure
	-	The CRP-VLDL complex, a predictor and marker of DIC, exists in vivo
Doyle S.	-	Coagulation factor content of solvent/detergent plasma compared to fresh frozen plasma
Drabløs P. A.	-	Prevalence of hyperhomocysteinemia among aluminum industry workers
	-	Elevated concentrations of nitrate in plasma from smokers
Dragomir E.	-	Effects of enoxaparin on high glucose induced activation of human endothelial cells
Dragoni F.	-	Thrombophilic screening in patients with paroxysmal nocturnal hemoglobinuria
Drai J.	-	Comparison of Clauss fibrinogen and fibrinogen measurement derived from aPTT and PT in diabetes mellitus and correlations with markers of glycemic equilibration
Drakopoulou A.	-	Effect of rFVIIa (NovSeven^®) on thrombin generation in patients with severe thrombocytopenia
Drenth A.	-	Heparin-induced anti-platelet antibodies in very low birth-weight infants
	-	Influence of argatroban alone and combined with oral anticoagulants on the assessment of coagulation factors
Drexler A.	-	Functional anti-heparin-PF4 antibody-mediated platelet–endothelial cell interactions: modulation of tissue factor activity involved in the HIT pathogenesis
	-	Bovine heparin results in higher generation of functional anti-heparin-PF4 antibodies than porcine heparin following coronary artery bypass surgery
	-	The importance of repeat laboratory testing in the diagnosis of heparin-induced thrombocytopenia
	-	Bivalirudin, a direct thrombin inhibitor, in the treatment of heparin-induced thrombocytopenia
	-	Frequency of heparin-platelet factor 4 antibodies in patients presenting to the emergency room with symptoms of thrombosis
	-	Trends in incidence and diagnosis of heparin-induced thrombocytopenia at a tertiary medical center
Dreyfus M.	-	Safety and efficacy of Fibrogammin P^® for the treatment of patients with severe FXIII deficiency
Dreyfus M.	-	Clinical and laboratory findings in a new case of congenital amegakaryocytic thrombocytopenia (CAMT)
	-	Fatal intra cerebral hemorrhage due to severe vitamin K deficiency disclosing cystic fibrosis
Drigo P.	-	Incidence of recurrent ischemic stroke in children with coagulation abnormalities
Driguez P.-A.	-	Antithrombin-mediated inhibition of factor IXa by synthetic oligosaccharides
Dropinski J.	-	Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarction
Drosopoulos J. H. F.	-	CD39 ecto-nucleotidase activity (metabolizing ATP to ADP to AMP) constitutes a homeostatic mechanism for control of platelet reactivity, depending on the ratio of ADPase to ATPase activity. Results from patients with coronary artery disease
Drouet L.	-	There is no north/south gradient distribution of the plasma fibrinogen level and of the C-148T Fg genotype in a French native population (The Fitenat Study)
	-	Differential geographic distribution of Factor V Leiden and Factor II Leiden in a French native population (the Fitenat study)
	-	Influence of R353Q factor VII gene polymorphism on the plasma FVII levels in a French native population (The Fitenat Study)
Drouet L.	-	A prospective randomized study to assess the usefulness of venous compression ultrasonography (CUS) and plasma d-dimer (DD) assay in the decision to discontinue treatment with a vitamin K antagonist (VKA) after an acute deep-vein thrombosis (DVT)
Drouet L.	-	Lack of correlation between HPA1 polymorphism and ADP induced platelet activation: study of a large cohort of normal subjects
	-	Age influence on D-Dimer in a large normal French population: the FITENAT study
	-	Aspirine resistance: a particularly high prevalence in patients after ventricular assist device implantation
	-	Early prediction of the sensitivity of warfarin in elderly patients by the fall in factor VII
	-	d-dimer levels: a prognostic value in patients with chronic atrial fibrillation
	-	Prevention of wine consumption on thrombosis but not on atherosclerosis in ApoE^-/- mice
	-	A comparative pharmacodynamic study of anti-Xa activity to evaluate the accumulation effect of Tinzaparin and Enoxaparin given at prophylactic dose over 8 days in elderly patients with impaired renal function
Droullé C.	-	Increasing the dosage of aspirin before percutaneaous coronary intervention: is there any effect in aspirin resistant patients? A randomized study
	-	Platelet function peculiarities throughout childhood: a flow cytometric study from healthy premature new-borns up to 15-year-old-children
Drugan A.	-	Modulation of systemic and placental hemostatic mechanisms by enoxaparin in women with gestational vascular complications
Druzin M. L.	-	Intrauterine growth retardation and recurrent pregnancy loss associated with prothrombin gene variants 20221C > T and 20209C > T
Druzin M.	-	Quantitative transcript profiling and novel gene identification of vascular endothelial cell subtypes by serial analysis of gene expression (SAGE)
Drzewoski J.	-	Is plasma homocysteine concentration different in diabetic and nondiabetic stroke patient up to the age of 55?
Du X.	-	Biphasic human platelet response to cGMP mediated via distinct signaling pathways: a predominant role for cAMP-dependent protein kinase in the cGMP-induced platelet inhibition and phosphorylation of vasodilator-stimulated phosphoprotein
Duanwei Z.	-	Simultaneous occurrence of lupus anticoagulant and factor VIII inhibitors in hyperththyroisis
Dubert L.	-	Variations of INR and Factor VII Level are linked to Cytochrome P450 2C9 genotype
Dubiel J.	-	Prognostic value of selected genetic variants of platelet glycoprotein receptors in prediction of thrombotic events after percutaneous coronary interventions
Dubois C.	-	Thrombin binding to GPIba induces platelet adhesion, aggregation and fibrin clot retraction supported by resting a Iibb 3 interaction with polymerized fibrin
Duboscq C.	-	Safety considerations of Enoxaparin as an alternative to oral anti-coagulants in high risk cardioembolic patients with a programed surgical procedure. SWITCH trial
	-	High levels of factors VIII, IX and XI in patients with a thromboembolic event
Duboullay C.	-	Efficacy and safety of the first nanofiltered plasma-derived FVIII (FACTANE®) in previously treated haemophilia A patients
Dubucquoi S.	-	Interest of diluted Russel viper venom time (dRVVT) in determining “pathogenic” lupus anticoagulants
Duca E.	-	Oral anti-coagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS)
Duchaussoy P.	-	Antithrombin-mediated inhibition of factor IXa by synthetic oligosaccharides
Duchose G.	-	There is no north/south gradient distribution of the plasma fibrinogen level and of the C-148T Fg genotype in a French native population (The Fitenat Study)
Ducruet T.	-	Resource utilization and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis
Dudas B.	-	Heparin derived oligosaccharides are capable of passing through the blood brain barrier: experimental evidence in a rat model
Dudek D.	-	Prognostic value of selected genetic variants of platelet glycoprotein receptors in prediction of thrombotic events after percutaneous coronary interventions
Duffels M. G. J.	-	High levels of coagulation factors IX or XI: risk factors for pulmonary embolism?
Duga S.	-	Allelic heterogeneity of severe factor V deficiency: doubling of the mutational spectrum of the factor V gene, and expression of the identified missense mutations
Duga S.	-	Congenital afibrinogenemia, identification of four novel homozygous mutations in the fibrinogen gene cluster: three point mutations and a 15-kb deletion
Duggan C.	-	Multivariate investigation of determinants of oral anti-coagulant stability
Dugina T. A.	-	Thrombin accelerates regeneration of mouse peripheral nerve in vivo
Duhamel A.	-	Interest of diluted Russel viper venom time (dRVVT) in determining “pathogenic” lupus anticoagulants
Duits A.	-	Elevated steady state serum sVCAM-1 levels occur from an early age in sickle cell patients, but are not related to vasoocclusive crises and acute chest syndrome frequency
	-	Levels of endothelial activation markers, D-dimer fragments and pro-inflammatory cytokines and sickle cell disease severity
	-	Reduced protein C and S activity and sickle cell disease severity
Duke L. M.	-	Molecular basis of the bleeding disorder caused by Prothrombin-Vancouver
Dulicek P.	-	Risk of venous thromboembolism during pregnancy and puerperium in women with homozygous form of F V Leiden
Dulitsky M.	-	Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study
Duman M.	-	Life threatening mediastinal-retroperitoneal hemorrhage in a child with moderate hemophilia A and high titer inhibitor: successful management with recombinant activated factor VII
Dumas J.	-	Crystal structure of benzamidine-Factor VIIa/soluble tissue factor at 1.87 Å resolution: mapping of calcium, magnesium, sodium, and zinc sites in the Factor VIIa structure
Dumas P. C.	-	Genetic and physical mapping of the platelet disorder in the fawn-hooded hypertensive rat
Dumo P.	-	Improving bridge-out therapy with low-molecular-weight heparin in an urban, inner city medical center
Dumont B.	-	Coagulation and endothelium activation in patients with scrub typhus
Duncan E.	-	Laboratory diagnosis of congenital thrombophilia: current and past practice in Australia
Duncan A.	-	Use of constant infusion of recombinant factor VIIa (NovoSeven) in the management of a recurrent subdural hematoma in a patient with severe hepatic coagulopathy
Duncan E. M.	-	Analysis of adult patients with von Willebrand disorder in South Australia
Duncan A.	-	Single-dose use of recombinant factor VIIa (NovoSeven) for correction of hepatic-induced coagulopathies prior to minor, invasive procedures
	-	Phospholipid-dependent impairment of the inhibitory properties of hirudin: the cause of false-positive assays for lupus anticoagulants (LAs)
Duncan W. J.	-	Pre-surgical reversal of warfarin using recombinant activated factor VII (rFVIIa) in a pediatric patient with prosthetic heart valves
Duncan E. M.	-	Low detection rate of antibodies to nonfunctional epitopes on factor VIII in patients with hemophilia A and negative for inhibitors by Bethesda assay
Dunkley S.	-	Recombinant factor VIIa used to control massive hemorrhage during renal transplantation surgery; vascular graft remained patent
Dunn A.	-	The impact of intravenous heparin administration on duration of hospitalization
Dunn A.	-	Clinical outcomes with the use of unfractionated heparin or low-molecular-weight heparin as perioperative bridging therapy in patients on long-term oral anti-coagulants: Rationale, objectives, and design of a large, long-term study (REGIMEN)
Dunn A.	-	Perioperative management of patients on oral anti-coagulants: a decision-analysis
Dunn E.	-	The relationship between nonenzymatic glycation and fibrin structure/function: a mechanism for increased vascular risk associated with hyperglycemia
Dunn A. S.	-	Perioperative management of patients on oral anti-coagulants: a systematic review
Dunn E.	-	Genetics of fibrin clot structure and interactions with factor XIII: a twin study
Dunn J.J.	-	Human blood platelets: RNA transcript profiling using microarray and serial analysis of gene expression
Dunoyer-Geindre S.	-	Effects of statins on adhesion molecules expression in endothelial cells
	-	High-level transgene expression of lentivirus-transduced human endothelial cells
	-	Aspirin inhibits VCAM-1 expression induced by antiphospholipid antibodies
Dunsch D.	-	A new protocol for inhibitor elimination in high responding hemophilia A patients
Dupont A.	-	ADP-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects
Dupouy D.	-	Shedding of active tissue factor (TF) by rat aortic smooth muscle cells (SMCs) undergoing apoptosis
Duran X.	-	Local blockade of the collagen binding domain to vWF-A3 with Saratin decreases thrombotic risk in human atherosclerotic lesions
	-	Local blockade of vWF binding epitopes on damaged vessel wall exposed collagen with Saratin inhibits thrombotic risk at different hemodynamic conditions
Dureau G.	-	Identification and characterisation of MIP-1b and VE-Cadherin as important markers of acute rejection after human heart transplantation
Durrani M. J.	-	Determination of free sulfhydryls in human factor VIII
Dusek L.	-	Multi-diagnostic retrospective study of risk factors of thrombosis in children with cancer – is there a space for multivariate predictive modeling?
Dusse L. M. S.	-	Markers of hypercoagulability in Brazilian patients with DVT undergoing oral anti-coagulation therapy
	-	Hemostatic parameters in Brazilian asymptomatic carriers of Factor V Leiden, prothrombin (G20210A) and methylenetetrahydrofolate reductase (C677T) mutations
Dutrey-Dupagne C.	-	A prospective randomized study to assess the usefulness of venous compression ultrasonography (CUS) and plasma d-dimer (DD) assay in the decision to discontinue treatment with a vitamin K antagonist (VKA) after an acute deep-vein thrombosis (DVT)
Duvall D.	-	Complications of plasma exchange in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome (TTP-HUS): A study of 149 consecutive patients 1996–2002
Dvorsak E.	-	MCP-1 as early marker for cell activation in septic patients
	-	TIMP-1, TIMP-2 and MMP-9 as prognostic markers for clinical outcome in sepsis
Dwyre L.	-	Issues arising in application of the ISTH disseminated intravascular coagulation (DIC) scoring system: the need for modification before prospective validation
Dyke C. K.	-	Effect of the direct factor Xa inhibitor, DX-9065a, on thrombin generation in patients with stable coronary artery disease
Dykes A. C.	-	The prevalence of, and molecular defects underlying, inherited Protein S deficiency in the general population
Dym R. J.	-	Factor VII levels, coronary artery disease, and MI
Dyr J. E.	-	Influence of oxidatively modified low-density lipoproteins on platelet function
Dyr J. E.	-	Resveratrol and trolox scavenge hydroxyl radicals produced in platelets activated by collagen
	-	Resveratrol and trolox scavenge hydroxyl radicals produced in platelets activated by collagen
Dyszkiewicz-Korpanty A.	-	Evaluation of platelet function analyzer (PFA-100), whole blood (WB), and platelet rich plasma (PRP) aggregation methods in detecting aspirin resistance
Dziedzina S.	-	Factor V Leiden and blood coagulation at the site of microvascular injury in coumadin treated patients and healthy control